LSD1 activates oncogenic super-enhancers in castration-resistant prostate cancer by forming nuclear condensates with BRD4

被引：0
|
作者：
Liu, Mingyu
Li, Muqing
Han, Dong
Wang, Zifeng
Han, Wanting
He, Housheng Hansen
Gao, Shuai
Cai, Changmeng
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4729
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4729
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
    Cai, Changmeng
    Chen, Sen
    Ng, Patrick
    Bubley, Glenn J.
    Nelson, Peter S.
    Mostaghel, Elahe A.
    Marck, Brett
    Matsumoto, Alvin M.
    Simon, Nicholas I.
    Wang, Hongyun
    Chen, Shaoyong
    Balk, Steven P.
    CANCER RESEARCH, 2011, 71 (20) : 6503 - 6513
  • [32] Elusive biomarkers of sensitivity to combined PD1/CTLA4 blockade in metastatic castration-resistant prostate cancer
    Antonarakis, E. S.
    ANNALS OF ONCOLOGY, 2024, 35 (12)
  • [33] Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis
    Xiao, Lijia
    Wang, Yuliang
    Xu, Kexin
    Hu, Hao
    Xu, Zhenyu
    Wu, Dinglan
    Wang, Zhu
    You, Wenxing
    Ng, Chi-Fai
    Yu, Shan
    Chan, Franky Leung
    CANCER RESEARCH, 2018, 78 (09) : 2205 - 2218
  • [34] TARGETING TR4 NUCLEAR RECEPTOR WITH ANTAGONIST BEXAROTENE INCREASES DOCETAXEL SENSITIVITY TO BETTER SUPPRESS THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION
    Hu, Linyi
    Sun, Yin
    Luo, Jie
    He, Xiang
    Ye, Meihua
    Li, Gonghui
    Zhang, Yong
    Bai, Jian
    Zhang, Dahong
    Chang, Chawnshang
    JOURNAL OF UROLOGY, 2021, 206 : E55 - E56
  • [35] Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression
    Hu, Linyi
    Sun, Yin
    Luo, Jie
    He, Xiang
    Ye, Meihua
    Li, Gonghui
    Zhang, Yong
    Bai, Jian
    Zhang, Dahong
    Chang, Chawnshang
    ONCOGENE, 2020, 39 (09) : 1891 - 1903
  • [36] Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression
    Linyi Hu
    Yin Sun
    Jie Luo
    Xiang He
    Meihua Ye
    Gonghui Li
    Yong Zhang
    Jian Bai
    Dahong Zhang
    Chawnshang Chang
    Oncogene, 2020, 39 : 1891 - 1903
  • [37] Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4
    Zhang, Yanquan
    Fong, Ka Will
    Mao, Fengyi
    Wang, Ruixin
    Kong, Yifan
    Li, Chaohao
    Liu, Jinghui
    Li, Zhiguo
    Allison, Derek B.
    Napier, Dana
    Li, Daheng
    Liu, Jinpeng
    Wang, Chi
    Zhang, Yeqing
    Li, Guangbing
    Liu, Xiaoqi
    CANCER RESEARCH, 2023, 83 (07)
  • [38] LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex
    Shang, Zhiqun
    Yu, Jianpeng
    Sun, Libin
    Tian, Jing
    Zhu, Shimiao
    Zhang, Boya
    Dong, Qian
    Jiang, Ning
    Flores-Morales, Amilcar
    Chang, Chawnshang
    Niu, Yuanjie
    NUCLEIC ACIDS RESEARCH, 2019, 47 (08) : 4211 - 4225
  • [39] Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis
    Zou, Peiliang
    Chen, Zheng
    He, Qixiong
    Zhuo, Yumin
    PROSTATE, 2024, 84 (01): : 64 - 73
  • [40] A randomized trial of abiraterone acetate (AA) administered with 1 of 4 glucocorticoid (GC) regimens in metastatic castration-resistant prostate cancer (mCRPC) patients (pts).
    Attard, Gerhardt
    Merseburger, Axel S.
    Sternberg, Cora N.
    Cerbone, Linda
    Recine, Federica
    Jones, Robert J.
    Feyerabend, Susan
    Berruti, Alfredo
    Joniau, Steven
    Schatteman, Peter
    Geczi, Lajos
    Tenke, Peter
    Werbrouck, Patrick
    Lefresne, Florence
    Shelby, Florence Nave
    Lahaye, Marjolein
    Pick, Corinna
    Tombal, Bertrand F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345